Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Piomelli

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
The New England Journal of Medicine|April 17, 1986
Complete suppression of the symptoms of congenital erythropoietic porphyria by long-term treatment with high-level transfusionsS Piomelli, M B Poh-Fitzpatrick, C Seaman, et al.
The Journal of Clinical Investigation|December 1, 1975
Erythropoietic protoporphyria and lead intoxication: the molecular basis for difference in cutaneous photosensitivity. I. Different rates of disappearance of protoporphyrin from the erythrocytes, both in vivo and in vitroS Piomelli, A A Lamola, M F Poh-Fitzpatrick, et al.
The Journal of Clinical Investigation|December 1, 1975
Erythropoietic protoporphyria and lead intoxication: the molecular basis for difference in cutaneous photosensitivity. II. Different binding of erythrocyte protoporphyrin to hemoglobinA A Lamola, S Piomelli, M G Poh-Fitzpatrick, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1978
Separation of younger red cells with improved survival in vivo: an approach to chronic transfusion therapyS Piomelli, C Seaman, J Reibman, et al.
Science (New York, N.Y.)|December 5, 1980
Blood lead concentrations in a remote Himalayan populationS Piomelli, L Corash, M B Corash, et al.
Biochimica Et Biophysica Acta|April 30, 1993
A novel mutation in erythropoietic protoporphyria: an aberrant ferrochelatase mRNA caused by exon skipping during RNA splicingX Wang, M Poh-Fitzpatrick, D Carriero, et al.
Blood|August 1, 1971
G6PD deficiency and chronic hemolysis: four new mutants--relationships between clinical syndrome and enzyme kineticsM C Rattazzi, L M Corash, G E van Zanen, et al.
Stroke|January 1, 1991
Middle cerebral artery blood velocity and cerebral blood flow in sickle cell diseaseL M Brass, I Prohovnik, S G Pavlakis, et al.
Pediatric Radiology|January 1, 1995
MRI marrow observations in thalassemia: the effects of the primary disease, transfusional therapy, and chelationT L Levin, S S Sheth, C Ruzal-Shapiro, et al.
The American Journal of Cardiology|July 1, 1988
Cardiovascular adaptations to transfusion/chelation therapy of homozygote sickle cell anemiaJ W Gaffney, F Z Bierman, C M Donnelly, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
The New England Journal of Medicine|April 17, 1986
Complete suppression of the symptoms of congenital erythropoietic porphyria by long-term treatment with high-level transfusionsS Piomelli, M B Poh-Fitzpatrick, C Seaman, et al.
The Journal of Clinical Investigation|December 1, 1975
Erythropoietic protoporphyria and lead intoxication: the molecular basis for difference in cutaneous photosensitivity. I. Different rates of disappearance of protoporphyrin from the erythrocytes, both in vivo and in vitroS Piomelli, A A Lamola, M F Poh-Fitzpatrick, et al.
The Journal of Clinical Investigation|December 1, 1975
Erythropoietic protoporphyria and lead intoxication: the molecular basis for difference in cutaneous photosensitivity. II. Different binding of erythrocyte protoporphyrin to hemoglobinA A Lamola, S Piomelli, M G Poh-Fitzpatrick, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1978
Separation of younger red cells with improved survival in vivo: an approach to chronic transfusion therapyS Piomelli, C Seaman, J Reibman, et al.
Science (New York, N.Y.)|December 5, 1980
Blood lead concentrations in a remote Himalayan populationS Piomelli, L Corash, M B Corash, et al.
Biochimica Et Biophysica Acta|April 30, 1993
A novel mutation in erythropoietic protoporphyria: an aberrant ferrochelatase mRNA caused by exon skipping during RNA splicingX Wang, M Poh-Fitzpatrick, D Carriero, et al.
Blood|August 1, 1971
G6PD deficiency and chronic hemolysis: four new mutants--relationships between clinical syndrome and enzyme kineticsM C Rattazzi, L M Corash, G E van Zanen, et al.
Stroke|January 1, 1991
Middle cerebral artery blood velocity and cerebral blood flow in sickle cell diseaseL M Brass, I Prohovnik, S G Pavlakis, et al.
Pediatric Radiology|January 1, 1995
MRI marrow observations in thalassemia: the effects of the primary disease, transfusional therapy, and chelationT L Levin, S S Sheth, C Ruzal-Shapiro, et al.
The American Journal of Cardiology|July 1, 1988
Cardiovascular adaptations to transfusion/chelation therapy of homozygote sickle cell anemiaJ W Gaffney, F Z Bierman, C M Donnelly, et al.
Pageof 11